How many shares of VRTX does JENNISON ASSOCIATES LLC own?

As of 2026-Q2, JENNISON ASSOCIATES LLC holds 3M shares of VRTX (VERTEX PHARMACEUTICALS INC).

What is JENNISON ASSOCIATES LLC's VRTX position worth?

As of 2026-Q2, JENNISON ASSOCIATES LLC's VRTX position is worth $1.5B.

In 2026-Q2, JENNISON ASSOCIATES LLC increased their VRTX position (+9.4% change in shares).

Based on available 13F filings, JENNISON ASSOCIATES LLC first reported a position in VRTX in 2018-Q4. They have held the position across 31 quarters.

Position history for JENNISON ASSOCIATES LLC's holdings in VERTEX PHARMACEUTICALS INC

Current Value

$1.5B

Current Shares

Total Value Change

+$339.2M

Total Shares Change

-3.9M

Quarter-by-Quarter History

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2026-Q2 Latest	Increased	3M	+9.4%	$1.5B	0.9%	$496.73	49
2026-Q1	Decreased	2.7M	-15.7%	$1.2B	0.8%	$474.27	0
2025-Q4	Decreased	3.2M	-6.0%	$1.5B	0.9%	$453.74	0
2025-Q3	Decreased	3.5M	-43.8%	$1.4B	0.8%	$395.31	0
2025-Q2	Increased	6.2M	+21.5%	$2.7B	1.6%	$441.30	60
2025-Q1	Increased	5.1M	+17.3%	$2.5B	1.7%	$492.69	59
2024-Q4	Decreased	4.3M	-22.2%	$1.7B	1.1%	$399.35	0
2024-Q3	Increased	5.6M	+18.1%	$2.6B	1.6%	$462.88	59
2024-Q2	Decreased	4.7M	-1.7%	$2.2B	1.4%	$468.72	0
2024-Q1	Increased	4.8M	+21.2%	$2B	1.3%	$418.01	60
2023-Q4	Increased	3.9M	+3.9%	$1.6B	1.2%	$406.89	52
2023-Q3	Decreased	3.8M	-0.2%	$1.3B	1.1%	$347.74	0
2023-Q2	Decreased	3.8M	-16.9%	$1.3B	1.1%	$348.18	0
2023-Q1	Decreased	4.6M	-10.5%	$1.4B	1.3%	$312.16	0
2022-Q4	Increased	5.1M	+7.6%	$1.5B	1.5%	$288.78	54
2022-Q3	Increased	4.8M	+168.3%	$1.4B	1.4%	$292.80	81
2022-Q2	Increased	1.8M	+406.3%	$499.5M	0.5%	$280.35	60
2022-Q1	Decreased	350,090	-55.3%	$91.4M	0.1%	$256.52	0
2021-Q4	Decreased	783,389	-5.5%	$172M	0.1%	$222.45	0
2021-Q3	Increased	829,359	+4.7%	$150.4M	0.1%	$182.22	32
2021-Q2	Increased	791,828	+10.6%	$159.7M	0.1%	$196.78	40
2021-Q1	Decreased	715,789	-80.9%	$153.8M	0.1%	$212.99	0
2020-Q4	Increased	3.7M	+3.9%	$886.1M	0.6%	$232.68	47
2020-Q3	Decreased	3.6M	-18.3%	$982.1M	0.8%	$270.31	0
2020-Q2	Increased	4.4M	+1.3%	$1.3B	1.2%	$285.18	51
2020-Q1	Increased	4.4M	+22.1%	$1B	1.3%	$231.92	61
2019-Q4	Decreased	3.6M	-40.3%	$781.9M	0.8%	$218.97	0
2019-Q3	Decreased	6M	-5.8%	$1B	1.1%	$166.74	0
2019-Q2	Decreased	6.3M	-6.7%	$1.2B	1.2%	$183.38	0
2019-Q1	Decreased	6.8M	-2.0%	$1.3B	1.2%	$183.95	0
2018-Q4	New	6.9M	-	$1.2B	1.3%	$161.42	73